• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017 - Product Image Special Offer Sale Banner

Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017

  • ID: 2373479
  • January 2013
  • 193 Pages
  • Markets and Markets
Special Offer Banner
10%
OFF
Offer ends 31st Dec 2014

FEATURED COMPANIES

  • BIOCONTROL MEDICAL, LTD.
  • CYBERONICS, INC.
  • ENTEROMEDICS, INC.
  • NEURONETICS, INC.
  • NEUROSIGMA, INC.
  • RS MEDICAL
  • MORE

Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non–invasive treatment. With advancements in technology, neuromodulation is expected to become a promising therapeutic area and high growth industry in the next decade, as it offers symptomatic relief mainly from chronic pain, incontinence, heart failure, headache, depression, epilepsy, etc. The neuromodulation devices market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS).

The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is altered due to biological responses produced by electrical stimulation or drug infusion. These devices include small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation. Neuromodulation can have READ MORE >

FEATURED COMPANIES

  • BIOCONTROL MEDICAL, LTD.
  • CYBERONICS, INC.
  • ENTEROMEDICS, INC.
  • NEURONETICS, INC.
  • NEUROSIGMA, INC.
  • RS MEDICAL
  • MORE

1 INTRODUCTION

1.1 KEY TAKE-AWAYS

1.2 REPORT DESCRIPTION

1.3 MARKETS COVERED

1.4 RESEARCH METHODOLOGY

1.4.1 MARKET SIZE

1.4.2 MARKET SHARE

1.4.3 KEY DATA POINTS FROM SECONDARY SOURCES

1.4.4 KEY DATA POINTS FROM PRIMARY SOURCES

1.4.5 ASSUMPTIONS

1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

3.1 INTRODUCTION

3.2 MARKET SEGMENTATION

3.3 MARKET DYNAMICS

3.3.1 DRIVERS

3.3.1.1 Increasing incidence of neurological disorders to spur market growth

3.3.1.2 Unprecedented global aging to fuel market growth

3.3.1.3 Strong product pipeline to propel the market

3.3.1.4 Expanded target applications and new indications are expected to stimulate growth of neuromodulation devices

3.3.1.5 Investments and funds – an impetus for market growth

3.4 RESTRAINTS

3.4.1.1 An unfavourable reimbursement scenario hinders market growth

3.4.1.2 Lack of trained professionals likely to hamper market growth

3.5 MARKET SHARE ANALYSIS

4 GLOBAL NEUROMODULATION MARKET (INTERNAL & EXTERNAL)

4.1 INTRODUCTION

4.2 INTERNAL STIMULATION

4.2.1 SPINAL CORD STIMULATION (SCS) MARKET

4.2.1.1 Major applications

4.2.1.1.1 Failed back surgery syndrome

4.2.1.1.2 Chronic pain

4.2.1.1.3 Ischemia

4.2.2 DEEP BRAIN STIMULATION (DBS)

4.2.2.1 Major applications

4.2.2.1.1 Parkinson’s disease

4.2.2.1.2 Dystonia

4.2.2.1.3 Tremor

4.2.2.1.4 Alzheimer’s

4.2.3 SACRAL NERVE STIMULATION (SNS)

4.2.3.1 Major applications

4.2.3.1.1 Urine incontinence

4.2.3.1.2 Fecal incontinence

4.2.4 VAGUS NERVE STIMULATION (VNS)

4.2.4.1 Major applications

4.2.4.1.1 Epilepsy

4.2.4.1.2 Others

4.2.5 GASTRIC ELECTRICAL STIMULATION (GES)

4.3 EXTERNAL STIMULATION

4.3.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)

4.3.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)

5 GEOGRAPHIC ANALYSIS

5.1 INTRODUCTION

5.2 NORTH AMERICA

5.3 EUROPE

5.4 ASIA

5.5 REST OF THE WORLD

6 COMPETITIVE LANDSCAPE

6.1 INTRODUCTION

6.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES

6.3 NEW PRODUCT LAUNCH

6.4 EXPANSION

6.5 OTHER DEVELOPMENTS

6.6 APPROVALS

7 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*
7.1 ANM ADAPTIVE NEUROMODULATION GMBH

7.2 BIOCONTROL MEDICAL, LTD.

7.3 BOSTON SCIENTIFIC CORPORATION

7.4 CERBOMED GMBH

7.5 CYBERONICS, INC.

7.6 ENDOSTIM, INC.

7.7 ENTEROMEDICS, INC.

7.8 THE MAGSTIM COMPANY LIMITED

7.9 MEDTRONIC, INC.

7.10 NEURONETICS, INC.

7.11 NEUROPACE, INC.

7.12 NEUROSIGMA, INC.

7.13 NEVRO CORPORATION

7.14 RS MEDICAL

7.15 SPINAL MODULATION, INC.

7.16 ST. JUDE MEDICAL

7.17 SYNAPSE BIOMEDICAL, INC.

7.18 UROPLASTY, INC.

7.19 ZYNEX, INC.

*Details on financials, product & services, strategy, and developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 GLOBAL NEUROMODULATION MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)

TABLE 2 GLOBAL NEUROMODULATION MARKET, BY MODALITY,2010 – 2017 ($MILLION)

TABLE 3 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)

TABLE 4 SPINAL CORD STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010 – 2017 (NO OF UNITS)

TABLE 5 GLOBAL SPINAL CORD STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)

TABLE 6 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)

TABLE 7 DEEP BRAIN STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010-2017 (NO OF UNITS)

TABLE 8 GLOBAL DEEP BRAIN STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)

TABLE 9 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)

TABLE 10 SACRAL NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010 – 2017 (NO OF UNITS)

TABLE 11 GLOBAL SACRAL NERVE STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)

TABLE 12 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)

TABLE 13 VAGUS NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010 – 2017 (NO OF UNITS)

TABLE 14 GLOBAL VAGUS NERVE STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)

TABLE 15 GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)

TABLE 16 GASTRIC ELECTRICAL STIMULATION MARKET VOLUME,BY GEOGRAPHY, 2010 – 2017 (NO OF UNITS)

TABLE 17 GLOBAL GASTRIC ELECTRICAL STIMULATION MARKET,BY APPLICATION, 2010-2017 ($MILLION)

TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET,BY GEOGRAPHY, 2010 – 2017($MILLION)

TABLE 19 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO OF UNITS)

TABLE 20 TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)

TABLE 21 TRANSCRANIAL MAGNETIC STIMULATION MARKET VOLUME,BY GEOGRAPHY, 2010 – 2017 (NO OF UNITS)

TABLE 22 GLOBAL TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY APPLICATION, 2010 – 2017 ($MILLION)

TABLE 23 NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)

TABLE 24 EXTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)

TABLE 25 INTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)

TABLE 26 GLOBAL EXTERNAL NEUROMODULATION MARKET, BY MODALITY,2010 – 2017 ($MILLION)

TABLE 27 GLOBAL EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO OF UNITS)

TABLE 28 NORTH AMERICA: NEUROMODULATION DEVICES MARKET,BY PROCEDURE, 2010 – 2017 ($MILLION)

TABLE 29 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 30 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 31 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 32 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 33 NORTH AMERICA: SPINAL CORD STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 34 NORTH AMERICA: DEEP BRAIN STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 35 NORTH AMERICA: SACRAL NERVE STIMULATION, BY COUNTRY,2010 – 2017 ($MILLION)

TABLE 36 NORTH AMERICA: VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 37 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATION MARKET,BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 38 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 39 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 40 EUROPE: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)

TABLE 41 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 42 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 43 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 44 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 45 EUROPE: SPINAL CORD STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 46 EUROPE: DEEP BRAIN STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 47 EUROPE: SACRAL NERVE STIMULATION, BY REGION,2010 – 2017 ($MILLION)

TABLE 48 EUROPE: VAGUS NERVE STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 49 EUROPE: GASTRIC ELECTRICAL STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)

TABLE 50 EUROPE: TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY REGION, 2010 – 2017 ($MILLION)

TABLE 51 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)

TABLE 52 ASIA: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)

TABLE 53 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 54 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 55 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 56 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 57 ASIA: SPINAL CORD STIMULATION MARKET, BY COUNTRY,2010 – 2017 ($MILLION)

TABLE 58 ASIA: DEEP BRAIN STIMULATION MARKET, BY COUNTRY,2010 – 2017 ($MILLION)

TABLE 59 ASIA: SACRAL NERVE STIMULATION, BY COUNTRY,2010 – 2017 ($MILLION)

TABLE 60 ASIA: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 61 ASIA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)

TABLE 62 ROW: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)

TABLE 63 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 64 ROW: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 65 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)

TABLE 66 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)

TABLE 67 ROW: SPINAL CORD STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 68 ROW: DEEP BRAIN STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 69 ROW: SACRAL NERVE STIMULATION, BY REGION,2010 – 2017 ($MILLION)

TABLE 70 ROW: VAGUS NERVE STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 71 ROW: GASTRIC ELECTRICAL STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)

TABLE 72 ROW: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)

TABLE 73 ROW: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)

TABLE 74 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES, 2010 – 2012

TABLE 75 NEW PRODUCT LAUNCH, 2010 – 2012

TABLE 76 EXPANSION, 2010 – 2012

TABLE 77 OTHER DEVELOPMENTS, 2010 – 2012

TABLE 78 APPROVALS, 2010 – 2012

TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)

TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)

TABLE 81 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)

TABLE 82 CYBERONICS, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)

TABLE 83 CYBERONICS, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)

TABLE 84 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)

TABLE 85 MEDTRONIC, INC: TOTAL REVENUE, BY SEGMENTS,2009 – 2011 ($MILLION)

TABLE 86 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)

TABLE 87 ST. JUDE MEDICAL, INC: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)

TABLE 88 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY SEGMENTS,2009 – 2011 ($MILLION)

TABLE 89 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)

TABLE 90 UROPLASTY, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2010-2012 ($MILLION)

TABLE 91 UROPLASTY, INC.: TOTAL REVENUE, BY GEOGRAPHY,2010 – 2012 ($MILLION)

TABLE 92 ZYNEX, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)

TABLE 93 ZYNEX, INC.: TOTAL REVENUE, BY SEGMENTS,2009 – 2011 ($MILLION)

LIST OF FIGURES

FIGURE 1 NEUROMODULATION MARKET SEGMENTATION

FIGURE 2 MARKET DYNAMICS

FIGURE 3 NEUROMODULATION MARKET SHARE ANALYSIS, BY REVENUE, 2011

FIGURE 4 KEY GROWTH STRATEGIES, 2010 – 2012

- ANM ADAPTIVE NEUROMODULATION GMBH

- BIOCONTROL MEDICAL, LTD.

- BOSTON SCIENTIFIC CORPORATION

- CERBOMED GMBH

- CYBERONICS, INC.

- ENDOSTIM, INC.

- ENTEROMEDICS, INC.

- THE MAGSTIM COMPANY LIMITED

- MEDTRONIC, INC.

- NEURONETICS, INC.

- NEUROPACE, INC.

- NEUROSIGMA, INC.

- NEVRO CORPORATION

- RS MEDICAL

- SPINAL MODULATION, INC.

- ST. JUDE MEDICAL

- SYNAPSE BIOMEDICAL, INC.

- UROPLASTY, INC.

- ZYNEX, INC.

Question Does this product cover TMS and depression treatments?
Answer Both TMS and treatment resistant depression are covered within the report. The report also gives market size, CAGR ( 2012-2017), market volume (TMS) and market size by application i.e. for depression.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos